NOVARTIS AG (NVSEF)
Clinical trial NCT04857372 updates: 1. completion date: 2026-09-04 → 2027-01-08 2. primary completion date: 2026-09-04 → 2027-01-07
Clinical trial NCT04857372 updates: 1. completion date: 2026-09-04 → 2027-01-08 2. primary completion date: 2026-09-04 → 2027-01-07
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical